Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17548749 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
Conditions: Major Depression;   Bipolar Disorder;   Unipolar Depression
Interventions: Drug: triiodothyronine;   Drug: sertraline

Indicates status has not been verified in more than two years